BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for ContraFect Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-07-19 5:13 pm Sale |
2022-07-15 | 13G | ContraFect Corporation CFRX |
BIOTECHNOLOGY VALUE FUND L P | 23,091 4.500% |
-26,563 (-53.50%) |
Filing |
| 2021-04-15 4:06 pm Purchase |
2021-04-13 | 13G | ContraFect Corporation CFRX |
BIOTECHNOLOGY VALUE FUND L P | 49,654 10.100% |
13,292 (+36.56%) |
Filing |
| 2020-10-20 08:59 am Purchase |
2020-05-22 | 13G | ContraFect Corporation CFRX |
BIOTECHNOLOGY VALUE FUND L P | 36,361 9.990% |
36,361 (New Position) |
Filing |